Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yuto Baba"'
Autor:
Yuto Baba, Takeo Kosaka, Hiroaki Kobayashi, Kohei Nakamura, Shuji Mikami, Hiroshi Nishihara, Makoto Nakanishi, Mototsugu Oya
Publikováno v:
BMC Medical Genomics, Vol 15, Iss 1, Pp 1-7 (2022)
Abstract Background The use of whole-genome sequencing in clinical practice has revealed variable genomic characteristics across cancer types, one of which is whole-genome doubling (WGD), which describes the duplication of a complete set of chromosom
Externí odkaz:
https://doaj.org/article/5c0715b0b2974202a6c551149e8c58d5
Autor:
Shinnosuke Fujiwara, Masaru Ishida, Eri Arai, Yuto Baba, Tadatsugu Anno, Hiroaki Kobayashi, Yasumasa Miyazaki
Publikováno v:
IJU Case Reports, Vol 5, Iss 1, Pp 58-61 (2022)
Introduction Primary or metastatic urethral tumors are extremely rare. However, treatment strategies differ between primary and metastatic tumors. Therefore, establishing an accurate diagnosis is critically needed for initiating timely and appropriat
Externí odkaz:
https://doaj.org/article/1c192788118a41f19b4872ba29fd0fc0
Autor:
Hiroki Ide, Eiji Kikuchi, Koichiro Ogihara, Naoya Niwa, Keisuke Shigeta, Tsukasa Masuda, Yuto Baba, Ryuichi Mizuno, Mototsugu Oya
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Limited information is currently available on predictors of upper tract urothelial carcinoma (UTUC) recurrence in non-muscle-invasive bladder cancer (NMIBC) patients according to smoking history, although smoking probably contributes to urot
Externí odkaz:
https://doaj.org/article/7984864f958c4dd8a754a4a8907ca7d8
Autor:
Tadatsugu Anno, Nobuyuki Tanaka, Kimiharu Takamatsu, Kyohei Hakozaki, Ryohei Kufukihara, Yuto Baba, Toshikazu Takeda, Kazuhiro Matsumoto, Shinya Morita, Takeo Kosaka, Shuji Mikami, Hiroshi Nishihara, Ryuichi Mizuno, Mototsugu Oya
Publikováno v:
Cancer Immunology, Immunotherapy. 72:1779-1788
Autor:
Yuto Baba, Takeo Kosaka, Kohei Nakamura, Yota Yasumizu, Nobuyuki Tanaka, Toshikazu Takeda, Kazuhiro Matsumoto, Shinya Morita, Ryuichi Mizuno, Hiroshi Nishihara, Mototsugu Oya
Publikováno v:
Journal of Urology. 209
Autor:
Yuto Baba, Yasumasa Miyazaki, Eri Arai, Tadatsugu Anno, Shinnosuke Fujiwara, Hiroaki Kobayashi, Masaru Ishida
Publikováno v:
IJU Case Reports, Vol 5, Iss 1, Pp 58-61 (2022)
IJU Case Reports
IJU Case Reports
Introduction Primary or metastatic urethral tumors are extremely rare. However, treatment strategies differ between primary and metastatic tumors. Therefore, establishing an accurate diagnosis is critically needed for initiating timely and appropriat
Autor:
Keisuke Shigeta, Masanori Hasegawa, Takako Hishiki, Yoshiko Naito, Yuto Baba, Shuji Mikami, Kazuhiro Matsumoto, Ryuichi Mizuno, Akira Miyajima, Eiji Kikuchi, Hideyuki Saya, Takeo Kosaka, Mototsugu Oya
Publikováno v:
The EMBO Journal. 42
Autor:
Ryuichi Mizuno, Yasuaki Murata, Yui Nishimoto, Koichiro Ogihara, Mototsugu Oya, Masafumi Oyama, Eiji Kikuchi, Keisuke Shigeta, Hirotaka Asakura, Yuto Baba, Masashi Matsushima
Publikováno v:
International Journal of Clinical Oncology. 26:2094-2103
The effects of the type of anesthesia (spinal (SA) vs. general (GA)) used for transurethral resection of bladder tumor (TURBT) on non-muscle invasive bladder cancer (NMIBC) recurrence and progression are controversial and our aim is to investigate th
Autor:
Kimiharu Takamatsu, Hiroshi Asanuma, Ryuichi Mizuno, Yuto Baba, Suguru Shirotake, Kazuhiro Matsumoto, Shuji Mikami, Takeo Kosaka, Toshikazu Takeda, Masafumi Oyama, Yota Yasumizu, Shinya Morita, Nobuyuki Tanaka, Mototsugu Oya
Publikováno v:
International Journal of Clinical Oncology. 26:1500-1505
The aim of this study was to evaluate the clinical significance of the on-treatment C-reactive protein (CRP) status during systemic treatment as the predictive marker for the response of subsequent nivolumab monotherapy in patients with refractory me
Autor:
Tansei Sanjo, Yuto Baba, Shuji Mikami, Mototsugu Oya, Takayuki Abe, Eiji Kikuchi, Masayuki Hagiwara, Kota Umeda, Keisuke Shigeta, Koichiro Ogihara, Ryuichi Mizuno, Tadatsugu Anno, Kazunori Shojo
Publikováno v:
European Urology Oncology. 3:756-763
Background The current guideline lacks evidence for creating individualized surveillance strategies for upper tract urothelial carcinoma (UTUC) patients after radical nephroureterectomy (RNU). Objective To create a novel risk model and to simulate in